Moser Othmar, Zaharieva Dessi, Adolfsson Peter, Battelino Tadej, Bracken Richard M, Buckingham Bruce A, Danne Thomas, Davis Elizabeth A, Dovc Klemen, Forlenza Gregory P, Gillard Pieter, Hofer Sabine E, Hovorka Roman, Jacobs Peter J, Mader Julia K, Mathieu Chantal, Nørgaard Kirsten, Oliver Nick S, O'Neal David N, Pemberton John, Rabasa-Lhoret Remi, Sherr Jennifer L, Sourij Harald, Tauschmann Martin, Yardley Jane E, Riddell Michael C
Department of Exercise Physiology and Metabolism (Sportsmedicine), University of Bayreuth, Bayreuth, Germany.
Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
Horm Res Paediatr. 2024 Dec 10:1-28. doi: 10.1159/000542287.
Regular physical activity and exercise (PA) are cornerstones of diabetes care for individuals with type 1 diabetes. In recent years, the availability of automated insulin delivery (AID) systems has improved the ability of people with type 1 diabetes to achieve the recommended glucose target ranges. PA provides additional health benefits but can cause glucose fluctuations, which challenges current AID systems. While an increasing number of clinical trials and reviews are being published on different AID systems and PA, it seems prudent at this time to collate this information and develop a position statement on the topic. This joint European Association for the Study of Diabetes (EASD)/International Society for Pediatric and Adolescent Diabetes (ISPAD) position statement reviews current evidence on AID systems and provides detailed clinical practice points for managing PA in children, adolescents and adults with type 1 diabetes using AID technology. It discusses each commercially available AID system individually and provides guidance on its use in PA. Additionally, it addresses different glucose responses to PA and provides stratified therapy options to maintain glucose levels within the target ranges for these age groups.
规律的体育活动和锻炼（PA）是1型糖尿病患者糖尿病护理的基石。近年来，自动胰岛素输送（AID）系统的出现提高了1型糖尿病患者实现推荐血糖目标范围的能力。体育活动能带来额外的健康益处，但会导致血糖波动，这对当前的AID系统构成了挑战。虽然关于不同AID系统和体育活动的临床试验和综述越来越多，但此时整理这些信息并就该主题制定一份立场声明似乎是明智的。这份欧洲糖尿病研究协会（EASD）/国际儿科和青少年糖尿病学会（ISPAD）联合立场声明回顾了关于AID系统的现有证据，并为使用AID技术的1型糖尿病儿童、青少年和成人管理体育活动提供了详细的临床实践要点。它分别讨论了每种市售的AID系统，并提供了其在体育活动中使用的指导。此外，它阐述了对体育活动的不同血糖反应，并提供了分层治疗方案，以将这些年龄组的血糖水平维持在目标范围内。
